Cancer develops as a result of the accumulation of mutations in cells. These mutations are not distributed evenly in chromosomes, so some regions hold more than others. A study headed by Institute for Research in Biomedicine (IRB Barcelona) researchers Salvador Aznar Benitah and Fran Supek examined whether the opening of…..
The International Society for Cell and Gene Therapy (ISCT), the global professional society of clinicians, researchers, regulatory specialists, technologists and industry partners in the cell and gene therapy sector, has published its first annual report detailing global cell and gene therapies (CGT) with market authorization. This report is intended to provide…..
Un entretien avec Régine Rouzier, présidente de la CRO Cap Research Quel élément central conditionne la réussite d’une étude de phase I ? La réussite d’une étude de phase I passe par la rapidité dans l’exécution et par la qualité du travail rendu. Ce sont les deux piliers fondamentaux d’un…..
An interview with Régine Rouzier, president of the CRO Cap Research What is the central issue to successfully perform a phase I trial? The success of a phase I study depends on the speed in execution and the excellence and quality of returned work. These are the two fundamental pillars…..
BioPharmAnalyses is happy to announce the release of the first issue of its « BRIEFING ON CART-T CELLS TRIALS » CAR-T cells therapies are at the forefront of innovation in oncology “BRIEFING ON CART-T CELLS TRIALS” provides you with an accurate overview to explore the latest trials in this hot and rapidly evolging…..